{"id":91207,"date":"2021-10-18T16:51:33","date_gmt":"2021-10-18T20:51:33","guid":{"rendered":"http:\/\/stateofthenation.co\/?p=91207"},"modified":"2021-10-18T18:32:06","modified_gmt":"2021-10-18T22:32:06","slug":"nebraska-ag-says-doctors-can-legally-prescribe-ivermectin-hcq-for-covid-19","status":"publish","type":"post","link":"https:\/\/stateofthenation.co\/?p=91207","title":{"rendered":"<h2><b>Nebraska AG Says Doctors Can Legally Prescribe Ivermectin &#038; HCQ for COVID-19<\/b><\/h2>"},"content":{"rendered":"<h1>Groundbreaking: Nebraska AG Says Doctors Can Legally Prescribe Ivermectin, HCQ for COVID, Calls Out FDA, CDC, Fauci, Media for \u2018Fueling Confusion and Misinformation\u2019<\/h1>\n<p><em>At the request of the Nebraska Department of Health, on Oct. 15, Nebraska Attorney General Doug Peterson issued a legal opinion that Nebraska healthcare providers can legally prescribe ivermectin and hydroxychloroquine for the treatment of COVID, so long as they obtain informed consent from the patient.<\/em><\/p>\n<p><!--more-->By Megan Redshaw<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-91210\" src=\"http:\/\/stateofthenation.co\/wp-content\/uploads\/2021\/10\/hydroxychloroquine-ivermectin-treatments-feature-800x417-1.jpg\" alt=\"\" width=\"800\" height=\"417\" srcset=\"https:\/\/stateofthenation.co\/wp-content\/uploads\/2021\/10\/hydroxychloroquine-ivermectin-treatments-feature-800x417-1.jpg 800w, https:\/\/stateofthenation.co\/wp-content\/uploads\/2021\/10\/hydroxychloroquine-ivermectin-treatments-feature-800x417-1-300x156.jpg 300w, https:\/\/stateofthenation.co\/wp-content\/uploads\/2021\/10\/hydroxychloroquine-ivermectin-treatments-feature-800x417-1-768x400.jpg 768w\" sizes=\"auto, (max-width: 800px) 100vw, 800px\" \/><\/p>\n<div class=\"post-heading\">\n<div class=\"featured noprint\"><\/div>\n<\/div>\n<div class=\"post-content\">\n<p>Few subjects have been more controversial than ivermectin and hydroxychloroquine \u2014 two long-established, inexpensive medications widely and successfully used in many parts of the world for the prevention and treatment of COVID.<\/p>\n<p>By contrast, the use of both medications against COVID has been largely suppressed in the U.S, where doctors have been <a href=\"https:\/\/www.nbcnews.com\/news\/us-news\/doctor-who-used-ivermectin-treat-covid-patients-inmates-under-investigation-n1277826\" target=\"_blank\" rel=\"noopener\">threatened<\/a> and <a href=\"https:\/\/www.cbc.ca\/news\/canada\/edmonton\/ivermectin-covid-alberta-nagase-1.6205075\" target=\"_blank\" rel=\"noopener\">punished <\/a>for prescribing them.<\/p>\n<p>On Oct. 15, Nebraska Attorney General (AG) Doug Peterson <a href=\"https:\/\/ago.nebraska.gov\/opinions\/prescription-ivermectin-or-hydroxychloroquine-label-medicines-prevention-or-treatment-covid\" target=\"_blank\" rel=\"noopener\">issued a legal opinion<\/a> that Nebraska healthcare providers <a href=\"https:\/\/www.ketv.com\/article\/nebraska-ag-issues-opinion-on-ivermectin-and-hydroxychloroquine-as-covid-19-treatments\/37973809\" target=\"_blank\" rel=\"noopener\">can legally prescribe<\/a> off-label medications like ivermectin and hydroxychloroquine for the treatment of <a href=\"https:\/\/childrenshealthdefense.org\/defender_category\/covid\/\">COVID<\/a>, so long as they obtain informed consent from the patient.<\/p>\n<p>However, if they did neglect to obtain consent, deceive, prescribe excessively high doses or other misconduct, they could be subject to discipline, Peterson wrote.<\/p>\n<p>The AG\u2019s office emphasized it was not recommending any specific treatment for COVID. \u201cThat is not our role,\u201d <a href=\"https:\/\/ago.nebraska.gov\/opinions\/prescription-ivermectin-or-hydroxychloroquine-label-medicines-prevention-or-treatment-covid\" target=\"_blank\" rel=\"noopener\">Peterson wrote<\/a>. \u201cRather, we address only the off-label early treatment options discussed in this opinion and conclude that the available evidence suggests they might work for some people.\u201d<\/p>\n<p>Peterson said allowing physicians to consider early treatments will free them to evaluate additional tools that could save lives, keep patients out of the hospital and provide relief for our already strained healthcare system.<\/p>\n<p>The <a href=\"https:\/\/ago.nebraska.gov\/sites\/ago.nebraska.gov\/files\/docs\/opinions\/21-017_0.pdf\" target=\"_blank\" rel=\"noopener\">opinion<\/a>, based on an assessment of relevant scientific literature, was rendered in response to a request by Dannette Smith, CEO of the Nebraska Department of Health and Human Services.<\/p>\n<p>Smith asked the AG\u2019s office to look into whether doctors could face discipline or legal action under <a href=\"https:\/\/nebraskalegislature.gov\/laws\/browse-chapters.php?chapter=38\" target=\"_blank\" rel=\"noopener\">Nebraska\u2019s Uniform Credential Act<\/a> (UCA) \u2014 meant to protect public health, safety and welfare \u2014 if they prescribed ivermectin or hydroxychloroquine.<\/p>\n<p>\u201cAfter receiving your question and conducting our investigation, we have found significant controversy and suspect information about potential COVID-19 treatments,\u201d <a href=\"https:\/\/ago.nebraska.gov\/sites\/ago.nebraska.gov\/files\/docs\/opinions\/21-017_0.pdf\" target=\"_blank\" rel=\"noopener\">Peterson wrote<\/a>.<\/p>\n<p>For example, a paper published in the Lancet \u2014\u00a0one of the most prestigious medical journals in the world \u2014 denounced hydroxychloroquine as dangerous, yet the statistics were flawed and the authors refused to provide analyzed data.<\/p>\n<p>The <a href=\"https:\/\/www.theguardian.com\/world\/2020\/jun\/04\/covid-19-lancet-retracts-paper-that-halted-hydroxychloroquine-trials\" target=\"_blank\" rel=\"noopener\">paper was retracted<\/a>, but not before countries stopped using the drug and trials were cancelled or interrupted.<\/p>\n<p>\u201cThe Lancet\u2019s own editor-in-chief admitted that the paper was a \u2018fabrication,\u2019 a \u2018monumental fraud\u2019 and a \u2018shocking example of research misconduct\u2019 in the middle of a global health emergency,\u201d Peterson wrote in the opinion.<\/p>\n<p>A recently published paper on COVID recognized that \u201cfor reasons that are yet to be clarified,\u201d early treatment has not been emphasized despite numerous U.S. healthcare providers advocating for early treatment and \u201cscores of treating and academic physicians\u201d \u2014 who have published papers in well respected journals \u2014 urging early interventions.<\/p>\n<p>Peterson cited <a href=\"https:\/\/ago.nebraska.gov\/sites\/ago.nebraska.gov\/files\/docs\/opinions\/21-017_0.pdf\" target=\"_blank\" rel=\"noopener\">numerous studies<\/a> showing ivermectin and hydroxychloroquine reduced mortality by up to 75% or more when used as a preventative or prophylaxis for COVID, suggesting hundreds of thousands of lives could have been saved had the drugs been widely used in America.<\/p>\n<p>\u201cEvery citizen \u2014 Democrat or Republican \u2014 should be grateful for Doug Peterson\u2019s thoughtful and courageous counteroffensive against the efforts of <a href=\"https:\/\/childrenshealthdefense.org\/defender_category\/big-pharma\/\">Big Pharma<\/a>, its captive federal regulators, and its media and social media allies to <a href=\"https:\/\/childrenshealthdefense.org\/defender\/vaccine-misinformation-medical-license-u-s-boards-warn-physicians\/\">silence doctors<\/a> and deny Americans life-saving treatments,\u201d Robert F. Kennedy Jr., chairman of Children\u2019s Health Defense, <a href=\"https:\/\/childrenshealthdefense.org\/defender\/\">told The Defender<\/a> via email.<\/p>\n<p>\u201cWe finally have a leader who puts constitutional rights, peer-reviewed science and human health above industry profits. Doug Peterson is uncowed and unbowed \u2014 a genuine hero on horseback for all Americans.\u201d Kennedy said.<\/p>\n<p>Children\u2019s Health Defense President Mary Holland agreed. \u201cThis Nebraska AG opinion lets doctors get back to being doctors \u2014 without being second-guessed by government, pharmacists and others interfering in the crucial doctor-patient relationship,\u201d Holland said.<\/p>\n<p>Although the AG\u2019s office did not rule out the possibility that other off-label drugs might show promise \u2014 either now or in the future \u2014 as a prophylaxis or treatment against COVID, it confined its opinion to ivermectin and hydroxychloroquine for the sake of brevity.<\/p>\n<p><strong>Nebraska AG highlights science on ivermectin<\/strong><\/p>\n<p>In his legal opinion, <a href=\"https:\/\/ago.nebraska.gov\/sites\/ago.nebraska.gov\/files\/docs\/opinions\/21-017_0.pdf\" target=\"_blank\" rel=\"noopener\">Peterson concluded<\/a> evidence showed ivermectin demonstrated striking effectiveness in preventing and treating COVID, and any side effects were primarily minor and transient. \u201cThus, the UCA does not preclude physicians from considering ivermectin for the prevention or treatment of COVID,\u201d Peterson wrote.<\/p>\n<p>In the decade leading up to the COVID pandemic, Peterson found numerous studies showing ivermectin\u2019s antiviral acti\u00advity against several RNA viruses by blocking the nuclear trafficking of viral proteins, adding to 50 years of research confirming ivermectin\u2019s antiviral effects.<\/p>\n<p>In addition, safety data for ivermectin showed side effects were \u201cvanishingly small.\u201d The latest statistics available through VigiAccess reported only 5,674 adverse drug reac\u00adtions to ivermectin between 1992 and October 13, 2021, an \u201cincredibly low\u201d number given that 3.7 billion doses have been administered since the 1980s, Peterson wrote.<\/p>\n<p>Peterson cited several studies showing ivermectin led to <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/labs\/pmc\/articles\/PMC8248252\/\" target=\"_blank\" rel=\"noopener\">improvement of COVID outcomes<\/a> when used in early treatment or as a prophylaxis, while noting many studies with negative findings about ivermectin \u201c<a href=\"https:\/\/c19ivermectin.com\/fordham.html\" target=\"_blank\" rel=\"noopener\">excluded most available evidence<\/a>,\u201d <a href=\"https:\/\/covid19criticalcare.com\/wp-content\/uploads\/2021\/09\/Response-to-Elgazzar.pdf\" target=\"_blank\" rel=\"noopener\">cherry picked data<\/a> within studies, misreported data, made <a href=\"https:\/\/c19ivermectin.com\/fordham.html\" target=\"_blank\" rel=\"noopener\">unsupported assertions<\/a> of adverse reactions to ivermectin and had \u201c<a href=\"https:\/\/covid19criticalcare.com\/wp-content\/uploads\/2021\/09\/Response-to-Elgazzar.pdf\" target=\"_blank\" rel=\"noopener\">conclusions<\/a>that did follow from evidence.\u201d<\/p>\n<p>Peterson also found that <a href=\"https:\/\/ago.nebraska.gov\/sites\/ago.nebraska.gov\/files\/docs\/opinions\/21-017_0.pdf\" target=\"_blank\" rel=\"noopener\">epidemiological evidence<\/a> for ivermectin\u2019s effectiveness, derived by analyzing COVID-related data from various states, countries or regions is instructive in the context of a global pandemic.<\/p>\n<p>In one instance, a group of scholars <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33259913\/\" target=\"_blank\" rel=\"noopener\">analyzed data<\/a> comparing COVID rates of countries that routinely administer ivermectin as a prophylaxis and countries that did not. The research showed \u201ccountries with routine mass drug administration of pro\u00adphylactic \u2026 ivermectin have a significantly lower incidence of COVID-19.\u201d<\/p>\n<p>\u201cThis \u2018highly significant\u2019 correlation manifests itself not only \u2018in a worldwide context\u2019 but also when comparing African countries that regularly administer prophylactic \u2018ivermectin against parasitic infections\u2019 and African countries that do not,\u201d Peterson wrote. \u201cBased on these results, the researchers surmised that these results may be connected to ivermectin\u2019s ability to inhibit SARS-CoV-2 replication, which likely leads to lower infection rates.\u201d<\/p>\n<div class=\"defender-home-signup-bar background-blue noprint\">\n<p><strong>Nebraska AG calls out FDA, Fauci on hypocrisy on ivermectin<\/strong><\/p>\n<p>Many U.S. health agencies have now addressed the use of ivermectin for COVID. The National Institutes of Health (NIH) has <a href=\"https:\/\/ago.nebraska.gov\/sites\/ago.nebraska.gov\/files\/docs\/opinions\/21-017_0.pdf\">adopted a neutral position<\/a>, choosing not to recommend for or against the use of ivermectin \u2014\u00a0a change from its position in January 2021 where it discouraged use of the drug for treatment of COVID.<\/p>\n<p>Peterson wrote:<\/p>\n<p>\u201cThe reason for the change is the NIH recognized several randomized trials and retrospective cohort studies of ivermectin use in patients with COVID-19 have been published in peer-reviewed journals. And some of those studies reported positive outcomes, including shorter time to resolution of disease manifestations that were attributed to COVID-19, greater reduction in inflammatory marker levels, shorter time to viral clearance, [and] lower mortality rates in patients who received ivermectin than in patients who received comparator drugs or placebo.\u201d<\/p>\n<p>Yet, on Aug. 29, <a href=\"https:\/\/childrenshealthdefense.org\/defender\/robert-f-kennedy-jr-book-the-real-anthony-fauci\/\">Dr. Anthony Fauci<\/a>, director of the National Institute of Allergy and Infectious Diseases within the NIH, <a href=\"https:\/\/www.cnn.com\/videos\/health\/2021\/08\/29\/dr-anthony-fauci-ivermectin-covid-19-sotu-vpx.cnn\" target=\"_blank\" rel=\"noopener\">went on CNN<\/a> and announced \u201cthere is no clinical evidence\u201d that ivermectin works for the prevention or treatment of COVID. Fauci went on to reiterate that \u201cthere is no evidence whatsoever\u201d that it works.<\/p>\n<p>\u201cThis definitive claim directly contradicts the NIH\u2019s recognition that \u2018several randomized trials \u2026 published in peer-reviewed journals\u2019 have reported data indicating that ivermectin is effective as a COVI D-19 treatment,\u201d Peterson wrote.<\/p>\n<p>In March 2021, the FDA <a href=\"https:\/\/web.archive.org\/web\/20210902000515\/https:\/\/www.fda.gov\/consumers\/consumer-updates\/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19\" target=\"_blank\" rel=\"noopener\">posted a webpage<\/a>, \u201cWhy You Should Not Use lvermectin to Treat or Prevent COVID-19.\u201d<\/p>\n<p>\u201cAlthough the FDA\u2019s concern was stories of some people using the animal form of ivermectin or excessive doses of the human form, the title broadly condemned any use of ivermectin in connection with COVID-19,\u201d Peterson wrote. \u201cYet, there was no basis for its sweeping condemnation.\u201d<\/p>\n<p>Peterson wrote:<\/p>\n<p>\u201cIndeed, the FDA itself acknowledged on that very webpage (and continued to do so until the page changed on September 3, 2021) that the agency had not even \u2018reviewed data to support use of ivermectin in COVID-19 patients to treat or to prevent COVID-19.\u2019 But without reviewing the available data, which had long since been available and accumulating, it is unclear what basis the FDA had for denouncing ivermectin as a treatment or prophylaxis for COVID-19.<\/p>\n<p>\u201cOn that <a href=\"https:\/\/web.archive.org\/web\/20210902000515\/https:\/\/www.fda.gov\/consumers\/consumer-updates\/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19\" target=\"_blank\" rel=\"noopener\">same webpage<\/a>, the FDA also declared that \u2018[i]vermectin is not an anti-viral (a drug for treating viruses).\u2019 It did so while another one of its <a href=\"https:\/\/www.fda.gov\/animal-veterinary\/product-safety-information\/faq-covid-19-and-ivermectin-intended-animals\" target=\"_blank\" rel=\"noopener\">webpages<\/a> simultaneously cited a study in Antiviral Research that identified ivermectin as a medicine \u2018previously shown to have broad-spectrum anti-viral activity.\u2019\u201d<\/p>\n<p>\u201cIt is telling that the FDA deleted the line about ivermectin not being \u2018anti-viral\u2019 when it amended the first webpage on September 3, 2021,\u201d Peterson noted.<\/p>\n<p>Peterson said the FDA\u2019s most controversial statement on ivermectin was made on Aug. 21, when it posted a link on Twitter to its \u201cWhy You Should Not Use lvermectin\u201d webpage with this <a href=\"https:\/\/twitter.com\/US_FDA\/status\/1429050070243192839\" target=\"_blank\" rel=\"noopener\">statement<\/a>: \u201cYou are not a horse. You are not a cow. Seriously, y\u2019all. Stop it.\u201d<\/p>\n<p>\u201cThis message is troubling not only because it makes light of a serious matter but also because it inaccurately implies that ivermectin is only for horses or cows,\u201d Peterson wrote.<\/p>\n<p>Peterson said the FDA has assailed ivermectin\u2019s safety while ignoring the fact that physicians routinely prescribe medications for off-label use and that ivermectin is a \u201cparticularly well-tolerated medicine with an established safety record.\u201d<\/p>\n<p>Peterson added the FDA is ignoring several randomized controlled trials and at least one meta\u00adanalysis suggesting ivermectin is effective against COVID. He pointed out the Centers of Disease Control and Prevention has adopted a similar stance \u2014 unsupported by scientific evidence \u2014 and the media has fueled confusion and misinformation on the drug.<\/p>\n<p><strong>Peterson questions professional associations\u2019 stance on ivermectin<\/strong><\/p>\n<p>Professional associations in the U.S. and internationally have adopted conflicting positions on ivermectin and COVID. The American Medical Association (AMA), American Pharmacists Association (APhA) and American Society of Health-System Pharmacists (ASHP) <a href=\"https:\/\/www.ama-assn.org\/press-center\/press-releases\/ama-apha-ashp-statement-ending-use-ivermectin-treat-covid-19\">issued a statement<\/a> in September strongly opposing the ordering, prescribing or dispensing of ivermectin to prevent or treat COVID outside of a clinical trial.<\/p>\n<p>But their statement relied solely on the FDA\u2019s and CDC\u2019s suspect positions.<\/p>\n<p>The AMA, APhA and ASHP also mentioned a statement by Merck \u2014 the original patent-holder \u2014 opposing the use of ivermectin for COVID because of a \u201cconcerning lack of safety data in the majority of studies.\u201d<\/p>\n<p>\u201cBut <a href=\"https:\/\/childrenshealthdefense.org\/defender\/john-campbell-mercks-covid-molnupiravir-ivermectin\/\">Merck<\/a>, of all sources, knows that ivermectin is exceedingly safe, so the absence of safety data in recent studies should not be concerning to the company,\u201d Peterson wrote.<\/p>\n<p>Peterson called into question the objectivity of Merck in providing an opinion on ivermectin that U.S. health agencies are relying upon. \u201cWhy would ivermectin\u2019s original patent holder go out of its way to question this medicine by creating the impression that it might not be safe?\u201d Peterson asked. \u201cThere are at least two plausible reasons.\u201d<\/p>\n<p>Peterson explained:<\/p>\n<p>\u201cFirst, ivermectin is no longer under patent, so Merck does not profit from it anymore. That likely explains why Merck declined to \u2018conduct clinical trials\u2019 on ivermectin and COVID-19 when given the chance.<\/p>\n<p>\u201cSecond, Merck has a significant financial interest in the medical profession rejecting ivermectin as an early treatment for COVID-19. [T]he U.S. government has agreed to pay [Merck] about $1.2 billion for 1.7 million courses of its experimental COVID-19 treatment, if it is proven to work in an ongoing large trial and authorized by U.S. regulators.\u201d<\/p>\n<p>Merck\u2019s treatment is known as \u201cmolnupiravir,\u201d and aims to stop COVID from progressing when given early in the course of disease. When Merck announced Oct. 1, that preliminary studies indicated molnupiravir reduced hospitalizations and deaths by half, the drug maker\u2019s stock price immediately jumped to 12.3%.<\/p>\n<p>\u201cThus, if low-cost ivermectin works better than, or even the same as molnupiravir, that could <a href=\"https:\/\/childrenshealthdefense.org\/defender\/merck-price-gouging-taxpayer-funded-covid-drug\/\">cost Merck billions of dollars<\/a>,\u201d Peterson wrote.<\/p>\n<div class=\"twitter-tweet twitter-tweet-rendered\"><iframe id=\"twitter-widget-0\" class=\"\" title=\"Twitter Tweet\" src=\"https:\/\/platform.twitter.com\/embed\/Tweet.html?dnt=false&amp;embedId=twitter-widget-0&amp;features=eyJ0ZndfZXhwZXJpbWVudHNfY29va2llX2V4cGlyYXRpb24iOnsiYnVja2V0IjoxMjA5NjAwLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X2hvcml6b25fdHdlZXRfZW1iZWRfOTU1NSI6eyJidWNrZXQiOiJodGUiLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X3NwYWNlX2NhcmQiOnsiYnVja2V0Ijoib2ZmIiwidmVyc2lvbiI6bnVsbH19&amp;frame=false&amp;hideCard=false&amp;hideThread=false&amp;id=1446487295109091329&amp;lang=en&amp;origin=https%3A%2F%2Fchildrenshealthdefense.org%2Fdefender%2Fnebraska-ag-doug-peterson-legal-opinion-ivermectin-hcq-covid%2F&amp;sessionId=4536d676482a0106e04341689209d3dc0d41e787&amp;siteScreenName=ChildrensHD&amp;theme=light&amp;widgetsVersion=f001879%3A1634581029404&amp;width=550px\" frameborder=\"0\" scrolling=\"no\" allowfullscreen=\"allowfullscreen\" data-tweet-id=\"1446487295109091329\" data-mce-fragment=\"1\"><\/iframe><\/div>\n<p>&nbsp;<\/p>\n<p><strong>Peterson takes on science of hydroxychloroquine<\/strong><\/p>\n<p>Peterson said based on his review of the evidence, his office did not find clear and convin\u00adcing evidence that <a href=\"https:\/\/ago.nebraska.gov\/sites\/ago.nebraska.gov\/files\/docs\/opinions\/21-017_0.pdf\" target=\"_blank\" rel=\"noopener\">would warrant disciplining physicians<\/a> who prescribe hydroxychloroquine for the prevention or early treatment of COVID after first obtaining informed patient consent.<\/p>\n<p>Peterson pointed to similar findings with hydroxychloroquine \u2014 a less toxic derivative of a medicine named chloroquine \u2014 widely used since it was approved by the FDA in 1955 for treatment of malaria.<\/p>\n<p>Peterson noted that as early as 2004, a lab <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0006291X0401839X\" target=\"_blank\" rel=\"noopener\">study revealed<\/a> chloroquine was \u201can effective inhibitor of the replication of the severe acute respiratory syndrome coronavirus (SARS-CoV) in vitro\u201d and should \u201cbe considered for immediate use in the prevention and treatment of SARS-CoV infections.\u201d<\/p>\n<p>In 2005, another <a href=\"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-2-69\" target=\"_blank\" rel=\"noopener\">study showed<\/a> chloroquine had strong antiviral effects on SARS-CoV infection and was effective in preventing the spread of SARS-CoV in cell cultures.<\/p>\n<p>Other studies showed hydroxychloroquine exhibited antiviral properties that can inhibit SARS-CoV-2 virus entry, transmission and replication, and contains anti-inflammatory properties that <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/labs\/pmc\/articles\/PMC7836863\/\" target=\"_blank\" rel=\"noopener\">help regulate<\/a> pro-inflammatory <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2785020\/\" target=\"_blank\" rel=\"noopener\">cytokines<\/a>.<\/p>\n<p>Peterson wrote, \u201cmany large observational studies suggest that hydroxychloroquine significantly reduces the risk of hospitalization and death when administered to \u00adparticularly high-risk outpatients as part of early COVID-19 treatment.\u201d<\/p>\n<p>Peterson said the drug is considered to be so safe it can be prescribed for pregnant women, yet during the pandemic, the <a href=\"https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or\" target=\"_blank\" rel=\"noopener\">FDA raised questions<\/a> about hydroxychloroquine and adverse cardiac events.<\/p>\n<p>These concerns prompted one group of researchers to conduct a <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/labs\/pmc\/articles\/PMC8133889\/pdf\/ejr-8-2-100.pdf\" target=\"_blank\" rel=\"noopener\">systematic review<\/a> of the hydroxychloroquine safety literature pre-COVID. Their review indicated people taking hydroxychloroquine in appropriate doses \u201care at very low risk of experiencing cardiac [adverse events], particularly with short-term administration\u201d of the drug.<\/p>\n<p>Researchers noted COVID itself can cause cardiac problems, and there was no reason \u201cto think the medication itself had changed after 70 years of widespread use,\u201d Peterson wrote.<\/p>\n<p>Peterson said one piece of key flawed data had substantially contributed to safety concerns surrounding the drug \u2014 the admittedly fraudulent Lancet study that falsely claimed hydroxychloroquine increased frequency of ventricular arrhythmias when used for treatment of COVID.<\/p>\n<p>The findings were so startling that major drug trials involving hydroxychloroquine \u201cwere immediately halted\u201d and the World Health Organization pressured countries like Indonesia that were widely using hydroxychloroquine to ban it. Some countries, including France, Italy and Belgium, stopped using it for COVID altogether.<\/p>\n<p>Peterson wrote:<\/p>\n<p>\u201cThe problem, however, is that the study was <a href=\"https:\/\/www.theguardian.com\/commentisfree\/2020\/jun\/05\/lancet-had-to-do-one-of-the-biggest-retractions-in-modern-history-how-could-this-happen\" target=\"_blank\" rel=\"noopener\">based on false data<\/a> from a company named Surgisphere, whose founder and CEO Sapan Desai was a co-author on the published paper.<\/p>\n<p>\u201cThe data were so obviously flawed that journalists and outside researchers began raising concerns within days of the paper\u2019s publication. Even the Lancet\u2019s editor in chief, Dr. Richard Horton, admitted that the paper was a fabrication, a monumental fraud and a shocking example of research misconduct in the middle of a global health emergency.\u201d<\/p>\n<p>Despite calls for the Lancet to provide a full expansion of what happened, the publication declined to provide details for the retraction.<\/p>\n<p>As with ivermectin, the FDA and NIH adopted positions against the use of hydroxychloroquine for COVID \u2014 making assertions that were unsupported by data. The AMA, APhA and ASHP, which opposed ivermectin, also resisted hydroxychloroquine for the treatment of COVID.<\/p>\n<p>By contrast, the Association of American Physicians and Surgeons, and other physician groups, support the use of both ivermectin and hydroxychloroquine as an early treatment option for COVID. Peterson cited an article co-authored by more than 50 doctors in Reviews in Cardiovascular Medicine who advocated an <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33387997\/\" target=\"_blank\" rel=\"noopener\">early treatment protocol<\/a> that includes hydroxychloroquine as a key component.<\/p>\n<p><strong>Governing law allows physicians to prescribe ivermectin and hydroxychloroquine, AG says<\/strong><\/p>\n<p><a href=\"https:\/\/nebraskalegislature.gov\/laws\/statutes.php?statute=38-179\" target=\"_blank\" rel=\"noopener\">Neb. Rev. Stat. \u00a7 38-179<\/a> generally defines unprofessional conduct as a \u201cdeparture from or failure to conform to the standards of acceptable and prevailing practice of a profession or the ethics of the profession, regardless of whether a person, consumer or entity is injured, or conduct that is likely to deceive or defraud the public or is detrimental to the public interest.\u201d<\/p>\n<p>The regulation governing physicians states that unprofessional conduct includes:<\/p>\n<p>\u201c[c]onduct or practice outside the normal standard of care in the State of Nebraska which is or might be harmful or dangerous to the health of the patient or the public, not to include a single act of ordinary negligence.\u201d<\/p>\n<p>Peterson said healthcare providers do not violate the standard of care when they choose between two reasonable approaches to medicine.<\/p>\n<p>\u201cRegulations also indicate that physicians may utilize reasonable investigative or unproven therapies that reflect a reasonable approach to medicine so long as physicians obtain written informed patient consent,\u201d Peterson wrote.<\/p>\n<p>\u201cInformed consent concerns a doctor\u2019s duty to inform his or her patient, and it includes telling patients about the nature of the pertinent ailment or condition, the risks of the proposed treatment or procedure and the risks of any alternative methods of treatment, including the risks of failing to undergo any treatment at all.\u201d<\/p>\n<p><a href=\"https:\/\/ago.nebraska.gov\/sites\/ago.nebraska.gov\/files\/docs\/opinions\/21-017_0.pdf\" target=\"_blank\" rel=\"noopener\">Peterson said<\/a> this applies to prescribing medicine for purposes other than uses approved by the FDA, and that doing so falls within the standard of care repeatedly recognized by the courts.<\/p>\n<p>Peterson said the U.S. Supreme Court has also affirmed that \u201coff-label usage of medical devices\u201d is an \u201caccepted and necessary\u201d practice, and the FDA has held the position for decades that \u201ca physician may prescribe [a drug] for uses or in treatment regimens or patient populations that are not included in approved labeling.\u201d<\/p>\n<p>Peterson said the FDA has stated \u201chealthcare providers generally may prescribe [a] drug for an unapproved use when they judge that it is medically appropriate for their patient, and nothing in the federal Food, Drug and Cosmetic Act (\u201cFDCA\u201d) limit[s] the manner in which a physician may use an approved drug.\u201d<\/p>\n<p>In a <a href=\"https:\/\/www.ketv.com\/article\/teacher-reads-bedtime-story-to-students-on-facebook-live-1-day-after-undergoing-brain-surgery\/37980448\" target=\"_blank\" rel=\"noopener\">statement<\/a> to KETV NewsWatch 7, Nebraska\u2019s Department of Health and Human Services said:<\/p>\n<p>\u201cThe Department of Health and Human Services appreciates the AG\u2019s office delivering an opinion on this matter. The document is posted and available to medical providers as they determine appropriate course of treatment for their patients.\u201d<\/p>\n<\/div>\n<\/div>\n<p>___<br \/>\n<a href=\"https:\/\/childrenshealthdefense.org\/defender\/nebraska-ag-doug-peterson-legal-opinion-ivermectin-hcq-covid\/?utm_source=salsa&amp;eType=EmailBlastContent&amp;eId=fd563ff8-566c-4b2b-bb7f-643090df6bb8\">https:\/\/childrenshealthdefense.org\/defender\/nebraska-ag-doug-peterson-legal-opinion-ivermectin-hcq-covid\/?utm_source=salsa&amp;eType=EmailBlastContent&amp;eId=fd563ff8-566c-4b2b-bb7f-643090df6bb8<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Groundbreaking: Nebraska AG Says Doctors Can Legally Prescribe Ivermectin, HCQ for COVID, Calls Out FDA, CDC, Fauci, Media for \u2018Fueling Confusion and Misinformation\u2019 At the request of the Nebraska Department of Health, on Oct. 15, Nebraska Attorney General Doug Peterson &hellip; <a href=\"https:\/\/stateofthenation.co\/?p=91207\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-91207","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts\/91207","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=91207"}],"version-history":[{"count":0,"href":"https:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts\/91207\/revisions"}],"wp:attachment":[{"href":"https:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=91207"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=91207"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=91207"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}